메뉴 건너뛰기




Volumn 44, Issue 3, 2014, Pages 765-774

Medical nanoparticles for next generation drug delivery to the lungs

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; BECLOMETASONE; BUDESONIDE; CELL PENETRATING PEPTIDE; CISPLATIN; FORMOTEROL; KETOTIFEN FUMARATE; NANOCARRIER; NANOPARTICLE; PACLITAXEL; STEROID; DRUG; DRUG CARRIER;

EID: 84907373079     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00212813     Document Type: Review
Times cited : (117)

References (84)
  • 1
    • 77952482571 scopus 로고    scopus 로고
    • Technosphere insulin: An inhaled prandial insulin product
    • Neumiller JJ, Campbell RK. Technosphere insulin: an inhaled prandial insulin product. BioDrugs 2010; 24: 165-172.
    • (2010) BioDrugs , vol.24 , pp. 165-172
    • Neumiller, J.J.1    Campbell, R.K.2
  • 2
    • 79951577062 scopus 로고    scopus 로고
    • Influence of particle size on regional lung deposition - What evidence is there?
    • Carvalho TC, Peters JI, Williams RO 3rd. Influence of particle size on regional lung deposition - what evidence is there? Int J Pharm 2011; 406: 1-10.
    • (2011) Int J Pharm , vol.406 , pp. 1-10
    • Carvalho, T.C.1    Peters, J.I.2    Williams III, R.O.3
  • 3
    • 67649970063 scopus 로고    scopus 로고
    • Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
    • Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomed 2008; 3: 1-19.
    • (2008) Int J Nanomed , vol.3 , pp. 1-19
    • Smola, M.1    Vandamme, T.2    Sokolowski, A.3
  • 5
    • 33847127477 scopus 로고    scopus 로고
    • Particle engineering for pulmonary drug delivery
    • Chow AH, Tong HH, Chattopadhyay P, et al. Particle engineering for pulmonary drug delivery. Pharm Res 2007; 24: 411-437.
    • (2007) Pharm Res , vol.24 , pp. 411-437
    • Chow, A.H.1    Tong, H.H.2    Chattopadhyay, P.3
  • 6
    • 59649084577 scopus 로고    scopus 로고
    • Nano-salbutamol dry powder inhalation: A new approach for treating bronchoconstrictive conditions
    • Bhavna, Ahmad FJ, Mittal G, et al. Nano-salbutamol dry powder inhalation: a new approach for treating bronchoconstrictive conditions. Eur J Pharm Biopharm 2009; 71: 282-291.
    • (2009) Eur J Pharm Biopharm , vol.71 , pp. 282-291
    • Bhavna Ahmad, F.J.1    Mittal, G.2
  • 8
    • 84874897667 scopus 로고    scopus 로고
    • Therapeutic nanoparticles in clinics and under clinical evaluation
    • Schutz CA, Juillerat-Jeanneret L, Mueller H, et al. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomed (Lond) 2013; 8: 449-467.
    • (2013) Nanomed (Lond) , vol.8 , pp. 449-467
    • Schutz, C.A.1    Juillerat-Jeanneret, L.2    Mueller, H.3
  • 9
    • 49749133167 scopus 로고    scopus 로고
    • Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles
    • Wernig K, Griesbacher M, Andreae F, et al. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release 2008; 130: 192-198.
    • (2008) J Control Release , vol.130 , pp. 192-198
    • Wernig, K.1    Griesbacher, M.2    Andreae, F.3
  • 10
    • 79951950063 scopus 로고    scopus 로고
    • Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model
    • Oh YJ, Lee J, Seo JY, et al. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model. J Control Release 2011; 150: 56-62.
    • (2011) J Control Release , vol.150 , pp. 56-62
    • Oh, Y.J.1    Lee, J.2    Seo, J.Y.3
  • 11
    • 25144447412 scopus 로고    scopus 로고
    • Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
    • Ahmad Z, Sharma S, Khuller GK. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 2005; 26: 298-303.
    • (2005) Int J Antimicrob Agents , vol.26 , pp. 298-303
    • Ahmad, Z.1    Sharma, S.2    Khuller, G.K.3
  • 12
    • 33745904988 scopus 로고    scopus 로고
    • Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
    • Azarmi S, Tao X, Chen H, et al. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm 2006; 319: 155-161.
    • (2006) Int J Pharm , vol.319 , pp. 155-161
    • Azarmi, S.1    Tao, X.2    Chen, H.3
  • 13
    • 84890452320 scopus 로고    scopus 로고
    • Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: Efficacy and biofate in a lung cancer mouse model
    • Karra N, Nassar T, Ripin AN, et al. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. Small 2013; 9: 4221-4236.
    • (2013) Small , vol.9 , pp. 4221-4236
    • Karra, N.1    Nassar, T.2    Ripin, A.N.3
  • 14
    • 42349094203 scopus 로고    scopus 로고
    • Nanoparticles in medicine: Therapeutic applications and developments
    • Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008; 83: 761-769.
    • (2008) Clin Pharmacol Ther , vol.83 , pp. 761-769
    • Zhang, L.1    Gu, F.X.2    Chan, J.M.3
  • 15
    • 0038032150 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
    • Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161-177.
    • (2000) Eur J Pharm Biopharm , vol.50 , pp. 161-177
    • Muller, R.H.1    Mader, K.2    Gohla, S.3
  • 16
    • 81355147743 scopus 로고    scopus 로고
    • Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery
    • Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliver Rev 2011; 63: 1247-1256.
    • (2011) Adv Drug Deliver Rev , vol.63 , pp. 1247-1256
    • Yoo, J.W.1    Doshi, N.2    Mitragotri, S.3
  • 17
    • 84857119766 scopus 로고    scopus 로고
    • Recent advances in stealth coating of nanoparticle drug delivery systems
    • Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012; 4: 219-233.
    • (2012) Wiley Interdiscip Rev Nanomed Nanobiotechnol , vol.4 , pp. 219-233
    • Amoozgar, Z.1    Yeo, Y.2
  • 18
    • 84877267457 scopus 로고    scopus 로고
    • Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles
    • Yuan H, Chen CY, Chai GH, et al. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm 2013; 10: 1865-1873.
    • (2013) Mol Pharm , vol.10 , pp. 1865-1873
    • Yuan, H.1    Chen, C.Y.2    Chai, G.H.3
  • 19
    • 84870720550 scopus 로고    scopus 로고
    • Application of polysaccharides for surface modification of nanomedicines
    • Doh KO, Yeo Y. Application of polysaccharides for surface modification of nanomedicines. Ther Deliv 2012; 3: 1447-1456.
    • (2012) Ther Deliv , vol.3 , pp. 1447-1456
    • Doh, K.O.1    Yeo, Y.2
  • 20
    • 84873853768 scopus 로고    scopus 로고
    • Biomolecular coronas provide the biological identity of nanosized materials
    • Monopoli MP, Aberg C, Salvati A, et al. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012; 7: 779-786.
    • (2012) Nat Nanotechnol , vol.7 , pp. 779-786
    • Monopoli, M.P.1    Aberg, C.2    Salvati, A.3
  • 21
    • 84863678205 scopus 로고    scopus 로고
    • The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles
    • Ruge CA, Schaefer UF, Herrmann J, et al. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLos One 2012; 7: e40775.
    • (2012) PLos One , vol.7
    • Ruge, C.A.1    Schaefer, U.F.2    Herrmann, J.3
  • 22
    • 82255191648 scopus 로고    scopus 로고
    • Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A
    • Ruge CA, Kirch J, Canadas O, et al. Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 2011; 7: 690-693.
    • (2011) Nanomedicine , vol.7 , pp. 690-693
    • Ruge, C.A.1    Kirch, J.2    Canadas, O.3
  • 23
    • 70350653772 scopus 로고    scopus 로고
    • Interaction of nanoparticles with the pulmonary surfactant system
    • Schleh C, Hohlfeld JM. Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol 2009; 21: Suppl. 1, 97-103.
    • (2009) Inhal Toxicol , vol.21 , Issue.SUPPL. 1 , pp. 97-103
    • Schleh, C.1    Hohlfeld, J.M.2
  • 24
    • 84880081982 scopus 로고    scopus 로고
    • Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles
    • Kendall M, Ding P, Mackay RM, et al. Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 2013; 7: 963-973.
    • (2013) Nanotoxicology , vol.7 , pp. 963-973
    • Kendall, M.1    Ding, P.2    Mackay, R.M.3
  • 25
    • 78049455169 scopus 로고    scopus 로고
    • Interaction of soot derived multi-carbon nanoparticles with lung surfactants and their possible internalization inside alveolar cavity
    • Kumar P, Bohidar HB. Interaction of soot derived multi-carbon nanoparticles with lung surfactants and their possible internalization inside alveolar cavity. Indian J Exp Biol 2010; 48: 1037-1042.
    • (2010) Indian J Exp Biol , vol.48 , pp. 1037-1042
    • Kumar, P.1    Bohidar, H.B.2
  • 26
    • 77957894948 scopus 로고    scopus 로고
    • Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies
    • Wang L, Castranova V, Mishra A, et al. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 2010; 7: 31.
    • (2010) Part Fibre Toxicol , vol.7 , pp. 31
    • Wang, L.1    Castranova, V.2    Mishra, A.3
  • 27
    • 0033839080 scopus 로고    scopus 로고
    • Openings between defective endothelial cells explain tumor vessel leakiness
    • Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156: 1363-1380.
    • (2000) Am J Pathol , vol.156 , pp. 1363-1380
    • Hashizume, H.1    Baluk, P.2    Morikawa, S.3
  • 28
    • 84859487837 scopus 로고    scopus 로고
    • Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
    • Fasol U, Frost A, Buchert M, et al. Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. Ann Oncol 2012; 23: 1030-1036.
    • (2012) Ann Oncol , vol.23 , pp. 1030-1036
    • Fasol, U.1    Frost, A.2    Buchert, M.3
  • 29
    • 34147102301 scopus 로고    scopus 로고
    • Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages
    • Hirota K, Hasegawa T, Hinata H, et al. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages. J Control Release 2007; 119: 69-76.
    • (2007) J Control Release , vol.119 , pp. 69-76
    • Hirota, K.1    Hasegawa, T.2    Hinata, H.3
  • 31
    • 0141990623 scopus 로고    scopus 로고
    • Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
    • Schiffelers RM, Koning GA, ten Hagen TL, et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003; 91: 115-122.
    • (2003) J Control Release , vol.91 , pp. 115-122
    • Schiffelers, R.M.1    Koning, G.A.2    Ten Hagen, T.L.3
  • 32
    • 74849112431 scopus 로고    scopus 로고
    • Synergistic targeting of αvβ3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis
    • Kluza E, van der Schaft DW, Hautvast PA, et al. Synergistic targeting of αvβ3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett 2010; 10: 52-58.
    • (2010) Nano Lett , vol.10 , pp. 52-58
    • Kluza, E.1    Van Der Schaft, D.W.2    Hautvast, P.A.3
  • 33
    • 70350207175 scopus 로고    scopus 로고
    • Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting
    • Chen K, Xie J, Xu H, et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009; 30: 6912-6919.
    • (2009) Biomaterials , vol.30 , pp. 6912-6919
    • Chen, K.1    Xie, J.2    Xu, H.3
  • 34
    • 84874591329 scopus 로고    scopus 로고
    • Receptor-based targeting of therapeutics
    • Mehra NK, Mishra V, Jain NK. Receptor-based targeting of therapeutics. Ther Deliv 2013; 4: 369-394.
    • (2013) Ther Deliv , vol.4 , pp. 369-394
    • Mehra, N.K.1    Mishra, V.2    Jain, N.K.3
  • 35
    • 0343882023 scopus 로고    scopus 로고
    • Targeted drug delivery via the folate receptor
    • Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000; 41: 147-162.
    • (2000) Adv Drug Deliv Rev , vol.41 , pp. 147-162
    • Sudimack, J.1    Lee, R.J.2
  • 36
    • 1842638560 scopus 로고    scopus 로고
    • Folate receptor targeted biodegradable polymeric doxorubicin micelles
    • Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004; 96: 273-283.
    • (2004) J Control Release , vol.96 , pp. 273-283
    • Yoo, H.S.1    Park, T.G.2
  • 37
    • 84857371220 scopus 로고    scopus 로고
    • The transferrin receptor and the targeted delivery of therapeutic agents against cancer
    • Daniels TR, Bernabeu E, Rodriguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 2012; 1820: 291-317.
    • (2012) Biochim Biophys Acta , vol.1820 , pp. 291-317
    • Daniels, T.R.1    Bernabeu, E.2    Rodriguez, J.A.3
  • 38
    • 0036464722 scopus 로고    scopus 로고
    • Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells
    • Wiewrodt R, Thomas AP, Cipelletti L, et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002; 99: 912-922.
    • (2002) Blood , vol.99 , pp. 912-922
    • Wiewrodt, R.1    Thomas, A.P.2    Cipelletti, L.3
  • 39
    • 33748673542 scopus 로고    scopus 로고
    • pH-responsive shielding of non-viral gene vectors
    • Meyer M, Wagner E. pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv 2006; 3: 563-571.
    • (2006) Expert Opin Drug Deliv , vol.3 , pp. 563-571
    • Meyer, M.1    Wagner, E.2
  • 40
    • 67249151969 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate
    • Meyer M, Dohmen C, Philipp A, et al. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol Pharm 2009; 6: 752-762.
    • (2009) Mol Pharm , vol.6 , pp. 752-762
    • Meyer, M.1    Dohmen, C.2    Philipp, A.3
  • 41
    • 33845625261 scopus 로고    scopus 로고
    • Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
    • Hatakeyama H, Akita H, Kogure K, et al. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 2007; 14: 68-77.
    • (2007) Gene Ther , vol.14 , pp. 68-77
    • Hatakeyama, H.1    Akita, H.2    Kogure, K.3
  • 42
    • 84870249845 scopus 로고    scopus 로고
    • Crucial factors and emerging concepts in ultrasound-triggered drug delivery
    • Geers B, Dewitte H, De Smedt SC, et al. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J Control Release 2012; 164: 248-255.
    • (2012) J Control Release , vol.164 , pp. 248-255
    • Geers, B.1    Dewitte, H.2    De Smedt, S.C.3
  • 43
    • 84883196945 scopus 로고    scopus 로고
    • Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery
    • Sirsi SR, Fung C, Garg S, et al. Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery. Theranostics 2013; 3: 409-419.
    • (2013) Theranostics , vol.3 , pp. 409-419
    • Sirsi, S.R.1    Fung, C.2    Garg, S.3
  • 44
    • 84862700846 scopus 로고    scopus 로고
    • Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung
    • Hasenpusch G, Geiger J, Wagner K, et al. Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung. Pharm Res 2012; 29: 1308-1318.
    • (2012) Pharm Res , vol.29 , pp. 1308-1318
    • Hasenpusch, G.1    Geiger, J.2    Wagner, K.3
  • 45
    • 84885190174 scopus 로고    scopus 로고
    • New perspectives in nanomedicine
    • Thorley AJ, Tetley TD. New perspectives in nanomedicine. Pharmacol Ther 2013; 140: 176-185.
    • (2013) Pharmacol Ther , vol.140 , pp. 176-185
    • Thorley, A.J.1    Tetley, T.D.2
  • 47
    • 84904750312 scopus 로고    scopus 로고
    • A concise review of carbon nanotube's toxicology
    • in press DOI: 10.3402/nano.v4i0.21521
    • Madani SY, Mandel A, Seifalian AM. A concise review of carbon nanotube's toxicology. Nano Rev 2013 (in press DOI: 10.3402/nano.v4i0.21521).
    • (2013) Nano Rev
    • Madani, S.Y.1    Mandel, A.2    Seifalian, A.M.3
  • 48
    • 33644748178 scopus 로고    scopus 로고
    • Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers
    • Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357-3362.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 3357-3362
    • Singh, R.1    Pantarotto, D.2    Lacerda, L.3
  • 49
    • 32944482677 scopus 로고    scopus 로고
    • Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
    • Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005; 23: 7794-7803.
    • (2005) J Clin Oncol , vol.23 , pp. 7794-7803
    • Gradishar, W.J.1    Tjulandin, S.2    Davidson, N.3
  • 50
    • 84865654435 scopus 로고    scopus 로고
    • A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases
    • Ernsting MJ, Murakami M, Undzys E, et al. A docetaxel- carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases. J Control Release 2012; 162: 575-581.
    • (2012) J Control Release , vol.162 , pp. 575-581
    • Ernsting, M.J.1    Murakami, M.2    Undzys, E.3
  • 51
    • 34247897230 scopus 로고    scopus 로고
    • Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung
    • Wittgen BP, Kunst PW, van der Born K, et al. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res 2007; 13: 2414-2421.
    • (2007) Clin Cancer Res , vol.13 , pp. 2414-2421
    • Wittgen, B.P.1    Kunst, P.W.2    Van Der Born, K.3
  • 52
    • 70349679107 scopus 로고    scopus 로고
    • Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases
    • Latimer P, Menchaca M, Snyder RM, et al. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med 2009; 234: 1244-1252.
    • (2009) Exp Biol Med , vol.234 , pp. 1244-1252
    • Latimer, P.1    Menchaca, M.2    Snyder, R.M.3
  • 53
    • 1842479077 scopus 로고    scopus 로고
    • Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies
    • Verschraegen CF, Gilbert BE, Loyer E, et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 2004; 10: 2319-2326.
    • (2004) Clin Cancer Res , vol.10 , pp. 2319-2326
    • Verschraegen, C.F.1    Gilbert, B.E.2    Loyer, E.3
  • 54
    • 77951011298 scopus 로고    scopus 로고
    • Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer
    • Otterson GA, Villalona-Calero MA, Hicks W, et al. Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin Cancer Res 2010; 16: 2466-2473.
    • (2010) Clin Cancer Res , vol.16 , pp. 2466-2473
    • Otterson, G.A.1    Villalona-Calero, M.A.2    Hicks, W.3
  • 55
    • 46049096465 scopus 로고    scopus 로고
    • Molecular recognition of small-cell lung cancer cells using aptamers
    • Chen HW, Medley CD, Sefah K, et al. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 2008; 3: 991-1001.
    • (2008) ChemMedChem , vol.3 , pp. 991-1001
    • Chen, H.W.1    Medley, C.D.2    Sefah, K.3
  • 56
    • 70349326658 scopus 로고    scopus 로고
    • Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells
    • Zhao Z, Xu L, Shi X, et al. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst 2009; 134: 1808-1814.
    • (2009) Analyst , vol.134 , pp. 1808-1814
    • Zhao, Z.1    Xu, L.2    Shi, X.3
  • 57
    • 67349255031 scopus 로고    scopus 로고
    • The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation
    • Tseng CL, Su WY, Yen KC, et al. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009; 30: 3476-3485.
    • (2009) Biomaterials , vol.30 , pp. 3476-3485
    • Tseng, C.L.1    Su, W.Y.2    Yen, K.C.3
  • 58
    • 78650572411 scopus 로고    scopus 로고
    • Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice
    • Bhirde AA, Patel S, Sousa AA, et al. Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomed (Lond) 2010; 5: 1535-1546.
    • (2010) Nanomed (Lond) , vol.5 , pp. 1535-1546
    • Bhirde, A.A.1    Patel, S.2    Sousa, A.A.3
  • 59
    • 33750417183 scopus 로고    scopus 로고
    • Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
    • Li SD, Huang L. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm 2006; 3: 579-588.
    • (2006) Mol Pharm , vol.3 , pp. 579-588
    • Li, S.D.1    Huang, L.2
  • 60
    • 0035571761 scopus 로고    scopus 로고
    • Pulmonary disposition of budesonide from liposomal dry powder inhaler
    • Joshi M, Misra AN. Pulmonary disposition of budesonide from liposomal dry powder inhaler. Methods Find Exp Clin Pharmacol 2001; 23: 531-536.
    • (2001) Methods Find Exp Clin Pharmacol , vol.23 , pp. 531-536
    • Joshi, M.1    Misra, A.N.2
  • 61
    • 0036892679 scopus 로고    scopus 로고
    • Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids
    • Saari SM, Vidgren MT, Herrala J, et al. Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids. Resp Med 2002; 96: 999-1005.
    • (2002) Resp Med , vol.96 , pp. 999-1005
    • Saari, S.M.1    Vidgren, M.T.2    Herrala, J.3
  • 62
    • 0032924188 scopus 로고    scopus 로고
    • Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers
    • Saari M, Vidgren MT, Koskinen MO, et al. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharm 1999; 181: 1-9.
    • (1999) Int J Pharm , vol.181 , pp. 1-9
    • Saari, M.1    Vidgren, M.T.2    Koskinen, M.O.3
  • 63
    • 79952598362 scopus 로고    scopus 로고
    • Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine
    • Suk JS, Lai SK, Boylan NJ, et al. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomed (Lond) 2011; 6: 365-375.
    • (2011) Nanomed (Lond) , vol.6 , pp. 365-375
    • Suk, J.S.1    Lai, S.K.2    Boylan, N.J.3
  • 64
    • 47349122617 scopus 로고    scopus 로고
    • Biodegradable polymeric nanocarriers for pulmonary drug delivery
    • Rytting E, Nguyen J, Wang X, et al. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv 2008; 5: 629-639.
    • (2008) Expert Opin Drug Deliv , vol.5 , pp. 629-639
    • Rytting, E.1    Nguyen, J.2    Wang, X.3
  • 65
    • 60149103022 scopus 로고    scopus 로고
    • Extracellular barriers in respiratory gene therapy
    • Sanders N, Rudolph C, Braeckmans K, et al. Extracellular barriers in respiratory gene therapy. Adv Drug Deliver Rev 2009; 61: 115-127.
    • (2009) Adv Drug Deliver Rev , vol.61 , pp. 115-127
    • Sanders, N.1    Rudolph, C.2    Braeckmans, K.3
  • 66
    • 60149111908 scopus 로고    scopus 로고
    • Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
    • Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliver Rev 2009; 61: 158-171.
    • (2009) Adv Drug Deliver Rev , vol.61 , pp. 158-171
    • Lai, S.K.1    Wang, Y.Y.2    Hanes, J.3
  • 67
    • 84878002619 scopus 로고    scopus 로고
    • Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease
    • Geiser M, Quaile O, Wenk A, et al. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 2013; 10: 19.
    • (2013) Part Fibre Toxicol , vol.10 , pp. 19
    • Geiser, M.1    Quaile, O.2    Wenk, A.3
  • 68
    • 70350393883 scopus 로고    scopus 로고
    • Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model
    • Matsuo Y, Ishihara T, Ishizaki J, et al. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 2009; 260: 33-38.
    • (2009) Cell Immunol , vol.260 , pp. 33-38
    • Matsuo, Y.1    Ishihara, T.2    Ishizaki, J.3
  • 69
    • 84861415187 scopus 로고    scopus 로고
    • Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: Physicochemical characterization and in vitro, in vivo evaluations
    • Sahib MN, Darwis Y, Peh KK, et al. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Int J Nanomedicine 2011; 6: 2351-2366.
    • (2011) Int J Nanomedicine , vol.6 , pp. 2351-2366
    • Sahib, M.N.1    Darwis, Y.2    Peh, K.K.3
  • 70
    • 0035979417 scopus 로고    scopus 로고
    • Dry powder inhalation of liposomal ketotifen fumarate: Formulation and characterization
    • Joshi M, Misra A. Dry powder inhalation of liposomal ketotifen fumarate: formulation and characterization. Int J Pharm 2001; 223: 15-27.
    • (2001) Int J Pharm , vol.223 , pp. 15-27
    • Joshi, M.1    Misra, A.2
  • 71
    • 0037344143 scopus 로고    scopus 로고
    • Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung
    • Joshi M, Misra A. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung. Clin Exp Pharmacol Physiol 2003; 30: 153-156.
    • (2003) Clin Exp Pharmacol Physiol , vol.30 , pp. 153-156
    • Joshi, M.1    Misra, A.2
  • 72
    • 84872120268 scopus 로고    scopus 로고
    • Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans
    • Bruinenberg P, Serisier D, Cipolla D, et al. Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. Pediatr Pulm 2010; 354-354.
    • (2010) Pediatr Pulm , pp. 354-354
    • Bruinenberg, P.1    Serisier, D.2    Cipolla, D.3
  • 73
    • 67549135653 scopus 로고    scopus 로고
    • A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers
    • Weers J, Metzheiser B, Taylor G, et al. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 2009; 22: 131-138.
    • (2009) J Aerosol Med Pulm Drug Deliv , vol.22 , pp. 131-138
    • Weers, J.1    Metzheiser, B.2    Taylor, G.3
  • 74
    • 70349084570 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection
    • Okusanya OO, Bhavnani SM, Hammel J, et al. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother 2009; 53: 3847-3854.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3847-3854
    • Okusanya, O.O.1    Bhavnani, S.M.2    Hammel, J.3
  • 75
    • 0028560407 scopus 로고
    • Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis
    • Allen SD, Sorensen KN, Nejdl MJ, et al. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J Antimicrob Chemother 1994; 34: 1001-1013.
    • (1994) J Antimicrob Chemother , vol.34 , pp. 1001-1013
    • Allen, S.D.1    Sorensen, K.N.2    Nejdl, M.J.3
  • 76
    • 56949108347 scopus 로고    scopus 로고
    • Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial
    • Slobbe L, Boersma E, Rijnders BJ. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial. Pulm Pharmacol Ther 2008; 21: 855-859.
    • (2008) Pulm Pharmacol Ther , vol.21 , pp. 855-859
    • Slobbe, L.1    Boersma, E.2    Rijnders, B.J.3
  • 77
    • 77956930518 scopus 로고    scopus 로고
    • Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
    • Vij N, Min T, Marasigan R, et al. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnology 2010; 8: 22.
    • (2010) J Nanobiotechnology , vol.8 , pp. 22
    • Vij, N.1    Min, T.2    Marasigan, R.3
  • 78
    • 33750010667 scopus 로고    scopus 로고
    • Gene therapy for cystic fibrosis lung disease: Current status and future perspectives
    • Rosenecker J, Huth S, Rudolph C. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr Opin Mol Ther 2006; 8: 439-445.
    • (2006) Curr Opin Mol Ther , vol.8 , pp. 439-445
    • Rosenecker, J.1    Huth, S.2    Rudolph, C.3
  • 79
    • 84869773544 scopus 로고    scopus 로고
    • Liposomal delivery of proteins and peptides
    • Swaminathan J, Ehrhardt C. Liposomal delivery of proteins and peptides. Expert Opin Drug Deliv 2012; 9: 1489-1503.
    • (2012) Expert Opin Drug Deliv , vol.9 , pp. 1489-1503
    • Swaminathan, J.1    Ehrhardt, C.2
  • 80
    • 33646343208 scopus 로고    scopus 로고
    • Increased intracellular targeting to airway cells using octaarginine-coated liposomes: In vitro assessment of their suitability for inhalation
    • Cryan SA, Devocelle M, Moran PJ, et al. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation. Mol Pharm 2006; 3: 104-112.
    • (2006) Mol Pharm , vol.3 , pp. 104-112
    • Cryan, S.A.1    Devocelle, M.2    Moran, P.J.3
  • 82
    • 17144401470 scopus 로고    scopus 로고
    • Novel molecular approaches to cystic fibrosis gene therapy
    • Lee TW, Matthews DA, Blair GE. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J 2005; 387: 1-15.
    • (2005) Biochem J , vol.387 , pp. 1-15
    • Lee, T.W.1    Matthews, D.A.2    Blair, G.E.3
  • 83
    • 0030759153 scopus 로고    scopus 로고
    • Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo
    • Zabner J, Cheng SH, Meeker D, et al. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 1997; 100: 1529-1537.
    • (1997) J Clin Invest , vol.100 , pp. 1529-1537
    • Zabner, J.1    Cheng, S.H.2    Meeker, D.3
  • 84
    • 0034193342 scopus 로고    scopus 로고
    • Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: Comparison with protein therapy
    • Brigham KL, Lane KB, Meyrick B, et al. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy. Hum Gene Ther 2000; 11: 1023-1032.
    • (2000) Hum Gene Ther , vol.11 , pp. 1023-1032
    • Brigham, K.L.1    Lane, K.B.2    Meyrick, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.